Time is running out, only TWO weeks left to book!

Pharma Co-Crystals

With new exciting case studies and enhances methods of improving drug properties using co-crystals, this is your chance to hear the latest industry and academic advancements from world renowned experts.

Pharmaceutical Co-Crystals 2008, is the only conferences focusing on purely co-crystal drugs, and will provide you with the unique opportunity to network with individuals working within the field, with ten networking opportunities, you can really maximise your time out of office by gaining answers to all those niggling research questions.

Learn form the successes and failures of others on how to incorporate to best translate co-crystal properties, screening and design, into a commercially successful product

Download 2008’s agenda here!

Speakers:

• Dr Annette Bak, Associate Director, Pre-formulation and Basic Research Support, Merck, previously Amgen
• Professor Christer Aakeroy, Inorganic and Supramolecular Chemistry, Kansas State University
• Dr Scott Childs, Senior Research Investigator, Aptuit Inc
• Dr Laszlo Fabian, Senior Research Scientist, Cambridge Crystallography Data Centre and Pfizer Institute
• Bertrand Gellie, Director, European Patent Office
• Dr Rolf Hilfiker, Head of Department Solid-State Development, Solvias
• Associate Professor Nair Rodriguez-Hornedo, Department of Pharmaceutical Sciences, University of Michigan
• Dr Dainius Macikenas, Pharmaceutical Development Group Leader, Vertex Pharmaceuticals
• Dr Michael Millan, Director of Pharma, Avantium Technologies
• Professor Ashwini Nangia, Department of Chemistry, University of Hyderabad
• Dr Stefan Rehnmark, Chief Scientific Officer, Axcentua Pharmaceuticals
• Dr Simon Black, Principal Scientist, AstraZeneca
• Dr. Martin Weber, Partner, Jones Day LLP
• Dr Robert Wenslow, Senior Research Fellow, Merck & Co
• Professor and Chairperson, Mike Zawortoko, Department of Chemistry, University of South Florida

Hot Topics And What Will I Learn?

• The True Solubility Advantage of Co-Crystals, learn how to correlate the components of a compound with its properties to reduce time to market facilitated by Associate Professor Nair-Rodriguez Hornedo.
• Challenges to API Scale-Up, Filing and Manufacturing of Pharmaceutical Co-Crystals will enable you to incorporate lessons learnt for successful scale-up and increased productivity facilitated by Dr Robert Wenslow
• Patenting Co-Crystals at the European Patent Office" improve your route to compliance to maximise efficiency by incorporating Bertrand Gellie's insider hints and tips
• The Broader Opportunities for Co-Crystals in Drug Discovery and Development to enable you to maximise your research investment facilitated by Professor Mike Zawortoko

Co-location

To extend the networking opportunities within the conference, Pharmaceutical Co-Crystals 2008, will be co-locating with our Amorphous Materials conference, the amorphous conference will be looking at characterisation and quantifying the amorphous form, for successful combat and control but also how the amorphous form can be used to improve properties within drug compounds.

If you are not yet ready to register, feel free to request a reminder nearer the time.

Conference Partners

Featured Session Sponsors	Session Sponsor	Featured Exhibitor
Platinum Media Partner	Media Partners

[ Register Now ] · [ Next: Conference Day One: 23rd September, 2008 ]